ZA824622B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA824622B ZA824622B ZA824622A ZA824622A ZA824622B ZA 824622 B ZA824622 B ZA 824622B ZA 824622 A ZA824622 A ZA 824622A ZA 824622 A ZA824622 A ZA 824622A ZA 824622 B ZA824622 B ZA 824622B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8121315 | 1981-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA824622B true ZA824622B (en) | 1983-04-27 |
Family
ID=10523154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA824622A ZA824622B (en) | 1981-07-10 | 1982-06-29 | Pharmaceutical compositions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0069600A3 (de) |
JP (1) | JPS5810519A (de) |
AU (1) | AU8533582A (de) |
GB (1) | GB2100985A (de) |
ZA (1) | ZA824622B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
JP2835741B2 (ja) * | 1989-04-10 | 1998-12-14 | コニカ株式会社 | 枚葉カード類の樹脂ラミネート方法 |
FR2690340B1 (fr) * | 1992-04-24 | 1995-02-24 | Scr Newmed | Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. |
AU685741B2 (en) * | 1992-12-04 | 1998-01-29 | Mayor Pharmaceutical Laboratories, Inc. | Sprayable analgesic composition and method of use |
US5552406A (en) * | 1994-06-17 | 1996-09-03 | The Mclean Hospital Corporation | Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists |
US6264974B1 (en) | 1998-07-07 | 2001-07-24 | Salvagnini Italia Spa | Buccal and sublingual administration of physostigmine |
AU781537B2 (en) * | 1998-12-18 | 2005-05-26 | Palladin Healthcare International, Ltd. | Composition for treatment of burns |
DE19907328C2 (de) * | 1999-02-20 | 2002-10-24 | Johannes Reichardt | Verfahren und System zur visuellen Programmierung |
PT2561860T (pt) | 2002-05-31 | 2018-05-08 | Titan Pharmaceuticals Inc | Dispositivo polimérico implantável para a libertação prolongada de buprenorfina |
EP1610791B1 (de) | 2003-03-31 | 2011-02-23 | Titan Pharmaceuticals, Inc. | Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten |
NZ568313A (en) * | 2005-11-21 | 2011-11-25 | Schering Plough Ltd | Pharmaceutical compositions comprising buprenorphine |
MX2009000745A (es) | 2006-07-21 | 2009-04-16 | Biodelivery Sciences Int Inc | Dispositivos de suministro transmucosa con admision mejorada. |
GB2461681A (en) * | 2008-04-17 | 2010-01-13 | Pharmasol Ltd | Buprenorphine liquid spray formulation with solvent and antioxidant |
WO2010072398A2 (en) * | 2008-12-22 | 2010-07-01 | Boehringer Ingelheim Limited | Veterinary formulations |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
GB2481728B (en) * | 2010-06-30 | 2012-05-23 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
HRP20211539T1 (hr) * | 2011-09-19 | 2021-12-24 | Orexo Ab | Sublingvalne tablete otporne na zloupotrebu koje sadrže buprenorfin i nalokson |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
GB2487007B (en) * | 2012-03-19 | 2013-06-05 | Londonpharma Ltd | COC containers and delivery devices for the sublingual administration of opioids |
KR102660711B1 (ko) * | 2017-10-20 | 2024-04-26 | 키에시 파르마슈티시 엣스. 피. 에이. | 활성 성분으로서 오피오이드 수용체 효능제를 포함하는 약제학적 제제, 그의 제조 방법 및 치료적 사용 |
ES2965836T3 (es) * | 2018-01-22 | 2024-04-17 | Foresee Pharmaceuticals Co Ltd | Composición farmacéutica para administración de liberación mantenida de buprenorfina |
BR112021019901A2 (pt) * | 2019-04-18 | 2022-02-15 | Chiesi Farm Spa | Método para tratar síndrome de abstinência neonatal devido à retirada de opioides |
-
1982
- 1982-06-25 AU AU85335/82A patent/AU8533582A/en not_active Abandoned
- 1982-06-29 ZA ZA824622A patent/ZA824622B/xx unknown
- 1982-07-02 JP JP57115310A patent/JPS5810519A/ja active Pending
- 1982-07-07 GB GB08219681A patent/GB2100985A/en not_active Withdrawn
- 1982-07-08 EP EP82303582A patent/EP0069600A3/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU8533582A (en) | 1984-01-12 |
EP0069600A3 (de) | 1984-04-04 |
JPS5810519A (ja) | 1983-01-21 |
GB2100985A (en) | 1983-01-12 |
EP0069600A2 (de) | 1983-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH25637A (en) | Dipyridamole-containing pharmaceutical form | |
GB8326565D0 (en) | Pharmaceutical compositions | |
GB8327612D0 (en) | Pharmaceutical compositions | |
ZA824622B (en) | Pharmaceutical compositions | |
NZ201520A (en) | Substituted aminopyridazines and pharmaceutical compositions | |
ZA825397B (en) | Pharmaceutical compositions | |
ZA81136B (en) | Pharmaceutical compositions | |
ZA822856B (en) | Pharmaceutical compositions | |
GB2118176B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
GB8324133D0 (en) | Pharmaceutical compositions | |
ZA82652B (en) | Pharmaceutical compositions | |
GB2072504B (en) | Pharmaceutical compositions | |
ZA815700B (en) | Pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
DE3377696D1 (en) | Pharmaceutical compositions | |
GB2114001B (en) | Nasel pharmaceutical compositions | |
PT73952A (en) | Pharmaceutical compositions | |
ZW18582A1 (en) | Pharmaceutical compositions | |
KE3739A (en) | Pharmaceutical compositions | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8314736D0 (en) | Pharmaceutical compositions | |
GB8330810D0 (en) | Pharmaceutical compositions | |
ZA82186B (en) | Pharmaceutical compositions | |
GB8331068D0 (en) | Pharmaceutical compositions |